BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) at a glance

BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) is a company. It trades at $0.92, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Value (58/100) and its weakest is Safety (38/100). It carries above-market volatility, so expect larger swings.

Price

$0.92

Market cap

n/a

P/E ratio

n/a

Dividend yield

None

Beta

1.64

52-week range

$0.61 to $1.40